It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Abnormal deposition of extracellular matrix (ECM) in lung tissue is a characteristic of idiopathic pulmonary fibrosis (IPF). Increased collagen deposition is also accompanied by altered collagen organization. Collagen type XIV, a fibril-associated collagen, supports collagen fibril organization. Its status in IPF has not been described at the protein level yet. In this study, we utilized publicly available datasets for single-cell RNA-sequencing for characterizing collagen type XIV expression at the gene level. For protein level comparison, we applied immunohistochemical staining for collagen type XIV on lung tissue sections from IPF patients and compared it to lung tissue sections from never smoking and ex-smoking donors. Analyzing the relative amounts of collagen type XIV at the whole tissue level, as well as in parenchyma, airway wall and bronchial epithelium, we found consistently lower proportions of collagen type XIV in all lung tissue compartments across IPF samples. Our study suggests proportionally lower collagen type XIV in IPF lung tissues may have implications for the assembly of the ECM fibers potentially contributing to progression of fibrosis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University of Groningen, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
2 University of Groningen, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
3 University of Groningen, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Department of Molecular Pharmacology, Groningen Research Institute for Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
4 University of Groningen, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Department of Pulmonology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
5 University of Groningen, Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); University of Groningen, W.J. Kolff Institute for Biomedical Engineering and Materials Science-FB41, University Medical Center Groningen, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)